Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

Long-serving Roche chief executive Severin Schwan is stepping down, to be replaced next March by Thomas Schinecker, currently head of diagnostics at the Swiss group. Schwan (pictured above ...

After hours: February 14 at 7:28:54 PM EST ...

These CRA user IDs and passwords may have been obtained through sources external to the CRA, such as email phishing schemes or third party data leaks. CRA user IDs and passwords identified as being at ...

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program ...

Abstract: This paper provides an improved model-free adaptive control (IMFAC) strategy for solving the surface vessel trajectory tracking issue with time delay and restricted disturbance. Firstly, the ...

Pocket-sized and portable, the Samsung T7 external SSD delivers read/write speeds of up to 1,050/1,00 MB/s. The 2TB capacity will hold tons of content from class projects to important work ...

Due to scheduled maintenance, the EUROCONTROL website may be temporarily unavailable between 17:00 and 20:00 CEST today. This does not impact the operational websites. Our latest Data Snapshot ...